They have no exposure to the Australian downturn, and a weaker AUD boosts their earnings when converted back into Australian dollars.
- Healthcare: CSL Limited (ASX: CSL), ResMed Inc (ASX: RMD), Cochlear Limited (ASX: COH)
- Industrials: Brambles Limited (ASX: BXB), Aristocrat Leisure Limited (ASX: ALL)
- Financials: QBE Insurance Group Limited (ASX: QBE) and Macquarie Group Limited (ASX: MQG), both with large offshore operations
As a group, these stocks have outperformed in 2026, gaining 4-5% on average, although if we take Cochlear (COH) out of the equation, it’s closer to 14%!
- We believe offshore earners will continue to outperform into 2027, making this an important part of MMs’ screening process.